Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 14 661 182 270 SEK
- Likvida medel
- 381 392 665 SEK
- Övriga tillgångar och skulder
- -11 840 603 SEK
- Antal innehav
- 63
- Aktiv risk
- 2,12
- Standardavvikelse 24 månader
- 13,72
- Jämförelseindex
- MSCI World Health Care Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| Eli Lilly | 1 190 950 935 SEK | 8,12% | Health Care |
| AstraZeneca | 1 028 288 599 SEK | 7,01% | Health Care |
| AbbVie | 881 672 678 SEK | 6,01% | Health Care |
| Boston Scientific | 805 484 556 SEK | 5,49% | Health Care |
| Abbott Laboratories | 775 495 278 SEK | 5,29% | Health Care |
| Danaher | 745 903 785 SEK | 5,09% | Health Care |
| United Health Group | 609 678 299 SEK | 4,16% | Health Care |
| HCA Healthcare | 597 243 130 SEK | 4,07% | Health Care |
| McKesson | 581 567 945 SEK | 3,97% | Health Care |
| Steris | 567 434 129 SEK | 3,87% | Health Care |
| Gilead Sciences | 527 599 763 SEK | 3,60% | Health Care |
| Cencora | 505 020 509 SEK | 3,44% | Health Care |
| Novo Nordisk | 416 336 624 SEK | 2,84% | Health Care |
| Amgen | 397 263 744 SEK | 2,71% | Health Care |
| Vertex Pharmaceuticals | 342 449 220 SEK | 2,34% | Health Care |
| Roche | 310 428 742 SEK | 2,12% | Health Care |
| Merck | 297 386 632 SEK | 2,03% | Health Care |
| Merck | 284 840 465 SEK | 1,94% | Health Care |
| Royalty Pharma | 238 153 818 SEK | 1,62% | Health Care |
| Cooper Companies | 209 724 880 SEK | 1,43% | Health Care |
| ConvaTec Group | 151 571 962 SEK | 1,03% | Health Care |
| Elevance Health | 150 392 439 SEK | 1,03% | Health Care |
| Insulet | 144 436 198 SEK | 0,99% | Health Care |
| Amplifon | 144 091 690 SEK | 0,98% | Health Care |
| Regeneron Pharmaceuticals | 135 764 464 SEK | 0,93% | Health Care |
Branscher
Källa: Finansinspektionen.